Incyte (INCY) insider buying

Healthcare · Biotechnology · Market cap $21.8B

4 open-market purchases of INCY by Incyte's executives and directors since January 2026, worth $0 in total, from SEC Form 4 filings.

The most recent: Ro Khanna bought — on March 30, 2026.

The biggest buyer over the period is Ro Khanna: 4 purchases, $0.

By year

YearPurchasesValue
20264$0

Biggest buyers

InsiderBuysValue
Ro Khanna
4$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 30, 2026 Ro Khanna
0$90.33— —
Mar 30, 2026 Ro Khanna
0$90.33— —
Jan 29, 2026 Ro Khanna
0$101.08— —
Jan 29, 2026 Ro Khanna
0$101.08— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for INCY.
Open INCY in Investingly

Questions

Are Incyte insiders buying the stock?

4 open-market purchases of INCY by Incyte's executives and directors since January 2026, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on March 30, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Incyte's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.